PROF — Profound Medical Corp.
—
Nasdaq ·
Health Care ·
Health Care Equipment & Supplies ·
CIK 1628808 ·
Last close
$6.91
Market Cap
$252.49M
52W High
$8.95
52W Low
$4.80
ADV30
223,533
Next earnings
2026-11-05
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | Gross profit | Op income | Net income | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Jun 2026 | 2,483,000 | 1,947,000 | -11,066,000 | -9,540,000 | 62,385,000 | 38,271,000 | 12,577,000 |
| Mar 2026 | 5,337,000 | 3,832,000 | -8,021,000 | -7,053,000 | 73,456,000 | 50,295,000 | 14,032,000 |
| Dec 2025 | 5,977,000 | 3,991,000 | -7,369,000 | -8,175,000 | 77,475,000 | 59,723,000 | 11,041,000 |
| Sep 2025 | 5,289,000 | 3,931,000 | -8,913,000 | -7,977,000 | 42,305,000 | 24,826,000 | 10,162,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$-38,507,000
Investing CF
—
Financing CF
$41,428,000
CapEx
—
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$-1.24
As of
2026-08-09
Balance + Analyst (yfinance extras)
Retained Earnings
$-294,793,000
Inventory
$9,001,000
Receivables
$9,423,000
ST Investments
—
EBIT TTM
$-38,109,000
Pretax Income TTM
$-38,664,000
Interest Exp TTM
—
Analysts
5
Yahoo Snapshot (yfinance, live)
Total Revenue
$19,086,000
EBITDA
$-34,878,000
Free Cash Flow
$-24,819,624
Enterprise Value
$187,208,592
Total Cash
$38,271,000
Total Debt
$7,380,000
Shares Out
36,540,343
Trailing EPS
$-0.99
Book Value
$1.36
ROE
-73.5%
ROA
-39.5%
Div Yield
—
Annual Trend (SEC EDGAR, last 5y)
Revenues vs Net Income (last 5y)
| FY end | Revenues | Op income | Net income | Assets | Liabilities | Equity | Op cash flow |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 16,098,000 | -41,254,000 | -42,570,000 | 77,475,000 | 11,041,000 | 66,434,000 | -38,207,000 |
| Dec 2024 | 10,680,000 | -33,062,000 | -27,816,000 | 70,234,000 | 9,812,000 | 60,422,000 | -23,453,000 |
| Dec 2023 | 7,199,000 | -28,651,000 | -28,323,000 | 43,956,000 | 12,732,000 | 31,224,000 | -22,609,000 |
| Dec 2022 | 6,681,000 | -29,602,000 | -28,669,000 | 64,421,000 | 12,417,000 | 52,004,000 | -25,800,000 |
| Dec 2021 | — | — | — | — | — | — | — |
TTM Snapshot
Revenues TTM
$18,814,000
NetIncome TTM
$38,899,000
OpCashFlow TTM
—
Assets (Latest)
$73,456,000
Forward EPS
$-0.59
Max Pain — expiry 2026-10-16
max pain strike: $7.50 · spot: $6.94 · call oi: 883 · put oi: 1,342
Expected Move to 2026-10-16:
±$0.78
(11.17%) —
implied range
$6.17 –
$7.72
· ATM straddle on $7.50 strike
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| TMCI | TREACE MEDICAL CONCEPTS, INC. | $252.01M | $3.88 | — |
| TLSI | TriSalus Life Sciences, Inc. | $254.30M | $4.13 | — |
| ANIK | Anika Therapeutics, Inc. | $257.35M | $19.23 | — |
| OSUR | ORASURE TECHNOLOGIES INC | $261.74M | $3.80 | — |
| INFU | InfuSystem Holdings, Inc | $267.09M | $13.41 | — |
News headlines (Yahoo Finance, 1h cache)
Profound Medical and Telix Pharmaceuticals Partner to Advance Prostate Cancer Imaging and Treatment Education
2026-10-09 12:38 · Yahoo
Profound Medical and Telix Pharmaceuticals Enter Co-Education Agreement to Advance PSMA-Informed Prostate Care
2026-10-09 11:45 · Yahoo
Strength Seen in Profound Medical (PROF): Can Its 21.7% Jump Turn into More Strength?
2026-10-09 10:42 · Yahoo
Profound Medical to Participate in Lake Street’s 10th Annual Best Ideas Growth Conference
2026-09-03 12:15 · Yahoo
Profound Medical Announces Management Change
2026-08-14 20:30 · Yahoo
Profound Medical (PROF) Q2 2026 Earnings Call Transcript
2026-08-13 23:44 · Yahoo
Profound Medical Launches ‘Let's Huddle’, a Global Community Supporting Men Throughout Their Prostate Care Journey
2026-08-13 20:15 · Yahoo
Profound Medical (PROF) Q2 Earnings Surpass Estimates
2026-08-07 02:35 · Yahoo
Profound Medical Reports Strong Preliminary Third Quarter 2026 Revenue
2026-10-07 20:15 · Yahoo
3 Canadian AI Stocks With Up To 58% Earnings Growth
2026-10-04 05:08 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.